Financials data is unavailable for this security.
View more
Year on year Medifast Inc 's revenues fell -32.94% from 1.60bn to 1.07bn. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from 143.57m to 99.42m, a -30.75% decrease.
| Gross margin | 73.94% |
|---|---|
| Net profit margin | 3.81% |
| Operating margin | 4.45% |
| Return on assets | 9.58% |
|---|---|
| Return on equity | 15.01% |
| Return on investment | 13.89% |
More ▼
Cash flow in USDView more
In 2023, Medifast Inc increased its cash reserves by 7.70%, or 6.75m. The company earned 147.66m from its operations for a Cash Flow Margin of 13.77%. In addition the company used 61.05m on investing activities and also paid 79.79m in financing cash flows.
| Cash flow per share | 3.88 |
|---|---|
| Price/Cash flow per share | 4.85 |
| Book value per share | 18.77 |
|---|---|
| Tangible book value per share | 18.77 |
More ▼
Balance sheet in USDView more
| Current ratio | 2.98 |
|---|---|
| Quick ratio | 2.46 |
| Total debt/total equity | 0.00 |
|---|---|
| Total debt/total capital | 0.00 |
More ▼
Growth rates in USD
SmartText is unavailable
| Div yield(5 year avg) | 4.23% |
|---|---|
| Div growth rate (5 year) | 17.72% |
| Payout ratio (TTM) | 62.75% |
| EPS growth(5 years) | 14.53 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -77.88 |
More ▼
